Shedding light on Alzheimer's
May 25, 2011 in Medical research
Cardiff researchers have uncovered a molecular interaction that could not only help understand the causes of Alzheimers, but also shed light on how life began.
The team, led by Professor Trevor Dale at the School of Biosciences, is studying fibers formed between amyloid, a protein aggregate, and nucleic acids, the building blocks of DNA. Abnormal accumulation of amyloid in organs is thought to play a role in a number of neurogenerative diseases, including Alzheimers.
The Cardiff team has now discovered that interactions between these two components assists the growth of ANA fibers (Amyloid-Nucleic Acid Fibres).
Professor Dale said: "Some types of ANA fibres form plaques in the brain where they are toxic to nerve cells, causing damage and the symptoms of dementia. Our findings have importance for Alzheimers disease because it may be that we can find a way to stop the ANA fibres forming and protect the brain from harm."
Other forms of ANA fibres may also have been present on the early earth as life first began to emerge. "We think that these fibres may have actually been the first entities subject to Darwinian evolution", Professor Dale explained.
The research was published in the journal PLOS One and was funded by Alzheimers Research UK and the Leverhulme Trust.
Dr. Simon Ridley, Head of Research at Alzheimers Research UK, said: "If we can understand how amyloid forms and becomes toxic, we may be able to find out how to stop it, opening the door to developing new treatments for Alzheimers and other diseases. Research in Cardiff is making great progress towards defeating dementia."
Provided by
Cardiff University
-
Putting top brains to the test with Alzheimer's protein
Jan 31, 2011 |
not rated yet |
0
-
Understanding Alzheimer's: Scientists find new way to study disease
Nov 08, 2010 |
not rated yet |
0
-
Researchers open window on a little-studied form of dementia
Nov 17, 2010 |
not rated yet |
0
-
Scientists shed light on blood flow problems in dementia
Dec 06, 2010 |
not rated yet |
0
-
Alzheimer's changes detectable in healthy elderly
Dec 22, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
20 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
H. pylori, smoking trends, and gastric cancer in US men
Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...
Medical research
10 hours ago |
not rated yet |
0
Common food supplement fights degenerative brain disorders
Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...
Medical research
14 hours ago |
5 / 5 (2) |
0
|
Finding a family for a pair of orphan receptors in the brain
Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...
Medical research
15 hours ago |
5 / 5 (1) |
0
|
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Medical research
15 hours ago |
4.6 / 5 (7) |
0
|
Do men's and women's hearts burn fuel differently?
Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...
Medical research
18 hours ago |
not rated yet |
0
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Drugs found to both prevent and treat Alzheimer's disease in mice
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.